These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21988617)

  • 1. Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.
    Miyanaga N; Akaza H; Hinotsu S; Fujioka T; Naito S; Namiki M; Takahashi S; Hirao Y; Horie S; Tsukamoto T; Mori M; Tsuji H
    Cancer Sci; 2012 Jan; 103(1):125-30. PubMed ID: 21988617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.
    deVere White RW; Tsodikov A; Stapp EC; Soares SE; Fujii H; Hackman RM
    Nutr Cancer; 2010; 62(8):1036-43. PubMed ID: 21058191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of serum levels and dietary intake of isoflavone, and the novel bacterium Slackia sp. strain NATTS with the risk of prostate cancer: a case-control study among Japanese men.
    Nagata Y; Sugiyama Y; Fukuta F; Takayanagi A; Masumori N; Tsukamoto T; Akasaka H; Ohnishi H; Saitoh S; Miura T; Moriyama K; Tsuji H; Akaza H; Mori M
    Int Urol Nephrol; 2016 Sep; 48(9):1453-60. PubMed ID: 27262851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
    Pendleton JM; Tan WW; Anai S; Chang M; Hou W; Shiverick KT; Rosser CJ
    BMC Cancer; 2008 May; 8():132. PubMed ID: 18471323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls.
    Perez-Cornago A; Appleby PN; Boeing H; Gil L; Kyrø C; Ricceri F; Murphy N; Trichopoulou A; Tsilidis KK; Khaw KT; Luben RN; Gislefoss RE; Langseth H; Drake I; Sonestedt E; Wallström P; Stattin P; Johansson A; Landberg R; Nilsson LM; Ozasa K; Tamakoshi A; Mikami K; Kubo T; Sawada N; Tsugane S; Key TJ; Allen NE; Travis RC
    Int J Cancer; 2018 Dec; 143(11):2677-2686. PubMed ID: 29971774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men.
    Fujimoto K; Tanaka M; Hirao Y; Nagata Y; Mori M; Miyanaga N; Akaza H; Kim WJ
    Prostate Cancer Prostatic Dis; 2008; 11(3):252-7. PubMed ID: 18180805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
    Hamilton-Reeves JM; Banerjee S; Banerjee SK; Holzbeierlein JM; Thrasher JB; Kambhampati S; Keighley J; Van Veldhuizen P
    PLoS One; 2013; 8(7):e68331. PubMed ID: 23874588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial.
    Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A
    Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents.
    Akaza H; Miyanaga N; Takashima N; Naito S; Hirao Y; Tsukamoto T; Fujioka T; Mori M; Kim WJ; Song JM; Pantuck AJ
    Jpn J Clin Oncol; 2004 Feb; 34(2):86-9. PubMed ID: 15067102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men.
    Ahuja V; Miura K; Vishnu A; Fujiyoshi A; Evans R; Zaid M; Miyagawa N; Hisamatsu T; Kadota A; Okamura T; Ueshima H; Sekikawa A
    Br J Nutr; 2017 Jan; 117(2):260-266. PubMed ID: 28205492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial.
    Wu J; Oka J; Higuchi M; Tabata I; Toda T; Fujioka M; Fuku N; Teramoto T; Okuhira T; Ueno T; Uchiyama S; Urata K; Yamada K; Ishimi Y
    Metabolism; 2006 Apr; 55(4):423-33. PubMed ID: 16546471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial.
    Wu J; Oka J; Ezaki J; Ohtomo T; Ueno T; Uchiyama S; Toda T; Uehara M; Ishimi Y
    Menopause; 2007; 14(5):866-74. PubMed ID: 17464237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counts of Slackia sp. strain NATTS in intestinal flora are correlated to serum concentrations of equol both in prostate cancer cases and controls in Japanese men.
    Sugiyama Y; Nagata Y; Fukuta F; Takayanagi A; Masumori N; Tsukamoto T; Akasaka H; Ohnishi H; Saito S; Miura T; Moriyama K; Tsuji H; Akaza H; Mori M
    Asian Pac J Cancer Prev; 2014; 15(6):2693-7. PubMed ID: 24761887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.
    Tanaka M; Fujimoto K; Chihara Y; Torimoto K; Yoneda T; Tanaka N; Hirayama A; Miyanaga N; Akaza H; Hirao Y
    Prostate Cancer Prostatic Dis; 2009; 12(3):247-52. PubMed ID: 19597532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women.
    Gleason CE; Carlsson CM; Barnet JH; Meade SA; Setchell KD; Atwood CS; Johnson SC; Ries ML; Asthana S
    Age Ageing; 2009 Jan; 38(1):86-93. PubMed ID: 19054783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
    Gardner CD; Oelrich B; Liu JP; Feldman D; Franke AA; Brooks JD
    Prostate; 2009 May; 69(7):719-26. PubMed ID: 19180569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soy proteins and isoflavones reduce interleukin-6 but not serum lipids in older women: a randomized controlled trial.
    Mangano KM; Hutchins-Wiese HL; Kenny AM; Walsh SJ; Abourizk RH; Bruno RS; Lipcius R; Fall P; Kleppinger A; Kenyon-Pesce L; Prestwood KM; Kerstetter JE
    Nutr Res; 2013 Dec; 33(12):1026-33. PubMed ID: 24267042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.